bioRxivMolecular BiologyPreprint
Molecular Rewiring in TNNT2-Linked Hypertrophic Cardiomyopathy hiPSC-Derived Cardiomyocytes upon Metabolic Maturation
Homa Hamledari, Farah Jayousi, Sanam ShafaattalabiD, Saif DababnehiD, Ramon I. Klein GeltinkiD, Philipp F. LangeiD, Maksymilian ProndzynskiiD, Glen F. TibbitsiD, Sheila S. TevesiD
Abstract
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are widely used to model cardiac development and inherited cardiomyopathies, yet their immature metabolic state limits interpretation of disease-associated molecular programs. While multiple strategies promote structural and functional maturation, less is known about the molecular regulation of metabolic maturation as a distinct developmental transition. Here, we examine how metabolic maturation reshapes molecular and metabolic states in wild-type and TNNT2-linked hypertrophic cardiomyopathy (HCM) hiPSC-CMs. Using integrated transcriptomic, chromatin accessibility, proteomic, and metabolic profiling, we define the molecular trajectory associated with metabolic maturation in wild-type hiPSC-CMs, characterized by coordinated transcriptional and epigenetic remodeling, enhanced mitochondrial oxidative metabolism, and progressive suppression of mTORC1 signaling. In contrast, hiPSC-CMs carrying TNNT2 HCM variants (I79N+/- and R278C+/-) exhibit variant-specific deviations from this metabolic maturation trajectory. While early CM differentiation is largely preserved, metabolic maturation reveals defects in mitochondrial respiration and chromatin organization, with the more clinically severe I79N+/- variant showing sustained metabolic impairment. We further find that mTORC1 activity is temporally misregulated during metabolic maturation in HCM hiPSC-CMs, with reduced signaling at early stages and normalization at later time points. Pharmacological inhibition of mTORC1 with rapamycin partially improves disease-associated protein expression signatures in the I79N+/- variant, particularly when applied during early differentiation. Together, these findings demonstrate that TNNT2-linked HCM involves disrupted metabolic maturation programs coupled to altered gene regulatory states, highlighting metabolic maturation as a critical context for studying cardiomyopathy-associated molecular phenotypes in hiPSC-CMs.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- assay: metabolomics
- assay: ChIP-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lipid metabolism drives allele-specific early-stage hypertrophic cardiomyopathy
Arpana Vaniya, Anja Karlstaedt, … Maria Roselle Abraham·bioRxiv·Nov 10, 2023
- A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cells
G. Emanuelli, A. Zoccarato, … A. Shah·bioRxiv·Sep 28, 2020
- Maturation of human induced pluripotent stem cell-derived cardiomyocytes for modeling hypertrophic cardiomyopathy
W. E. Knight, Y. Cao, … K. Song·bioRxiv·Jan 16, 2020
- Hierarchical control of cardiomyocyte maturation and ischaemia sensitivity by metabolic culture conditions
Yuanzhao Cao, Chris Siu Yeung Chow, … Nathan J. Palpant·bioRxiv·Mar 15, 2026
- Metabolically-Driven Maturation of hiPSC-Cell Derived Heart-on-a-Chip
N. Huebsch, B. Charrez, … K. E. Healy·bioRxiv·Nov 14, 2020
- Multi-omic analysis reveals maturation programs in human pluripotent stem cell-derived cardiomyocytes during long-term culture
Austin K. Feeney, Aaron D. Simmons, … Sean P. Palecek·Journal of Molecular and Cellular CardiologyPeer-reviewed·Oct 2, 2026